Funds holding KalVista Pharmaceuticals Inc
ISIN US4834971032 · United States · LEI 529900Q7IDA3WUGRZA51
- Fund holders
- 137
- Of which ETFs
- 30 107 other funds
- Value held
- 251.6M $ 549.7K € · 67.4M SEK
- Share of capital
- 24.6 % of 51.2M shares on Mar 18, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,831 | 46.1K $ | 0.06 % | 0.01 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 2,756 | 55.5K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 2,682 | 54K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 2,567 | 68.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,465 | 49.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 2,375 | 38.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 2,370 | 38.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,334 | 38K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 2,216 | 59.1K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| First Trust Small Cap BuyWrite Income ETF First Trust Exchange-Traded Fund VI | 2,206 | 44.4K $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 1,804 | 29.4K $ | 0.10 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,661 | 27K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,514 | 40.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,371 | 22.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,162 | 18.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,094 | 22K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 936 | 18.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 911 | 18.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 900 | 18.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 834 | 16.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 600 | 12.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 487 | 9.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 433 | 11.5K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 390 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 332 | 6.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 236 | 6.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 192 | 3.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 128 | 2.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 97 | 2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 89 | 1.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 70 | 1.9K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 53 | 1.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 39 | 634.9 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 38 | 764.9 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 10 | 201.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 10 | 162.8 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 549.7K € | 0.67 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 3.81 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 2.52 % | as of Apr 30, 2026 ↗ |
| F/m Emerald Special Situations ETF RBB Fund, Inc. | 1.89 % | as of Apr 30, 2026 ↗ |
| BNY Mellon Small Cap Value Fund BNY Mellon Investment Funds I | 1.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Portfolio BNY MELLON VARIABLE INVESTMENT FUND | 0.98 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI Merger Arbitrage Fund Fidelity Greenwood Street Trust | 0.93 % | as of Apr 30, 2026 ↗ |
| Nomura Small Cap Growth Fund IVY FUNDS | 0.72 % | as of Mar 31, 2026 ↗ |
| SFT Nomura Small Cap Growth Fund Securian Funds Trust | 0.72 % | as of Mar 31, 2026 ↗ |
| Nomura VIP Small Cap Growth Series Ivy Variable Insurance Portfolios | 0.72 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.67 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 135 | +13 | 12,238,532 | +11.6 % |
| 2026Q1 | 122 | +3 | 10,970,157 | +3.5 % |
| 2025Q4 | 119 | 0 | 10,594,944 | +2.7 % |
| 2025Q3 | 119 | 0 | 10,321,235 | +2.8 % |
| 2025Q2 | 119 | +1 | 10,035,854 | -4.4 % |
| 2025Q1 | 118 | -4 | 10,499,830 | +0.4 % |
| 2024Q4 | 122 | -1 | 10,453,874 | +15.1 % |
| 2024Q3 | 123 | -2 | 9,086,140 | +59.0 % |
| 2024Q2 | 125 | +5 | 5,713,251 | +9.7 % |
| 2024Q1 | 120 | -4 | 5,209,673 | +12.9 % |
| 2023Q4 | 124 | 4,613,729 |
Institutional managers
175 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Venrock Adviser, LLC | 6,474,485 | 130.3M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 4,961,108 | 99.9M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,768,712 | 96M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 4,573,530 | 92.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,795,897 | 76.4M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,876,407 | 57.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 2,808,583 | 56.5M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,136,940 | 43M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,955,844 | 39.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,912,146 | 38.5M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,850,000 | 37.2M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 1,835,506 | 36.9M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 1,820,954 | 36.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 1,509,920 | 30.4M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 1,450,000 | 29.2M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 1,264,023 | 25.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,236,000 | 24.9M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 1,021,300 | 20.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 996,235 | 20.1M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 985,100 | 19.8M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 897,681 | 18.1M $ | as of Mar 31, 2026 |
| Freestone Grove Partners LP | 882,906 | 17.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 824,293 | 16.6M $ | as of Mar 31, 2026 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 805,762 | 16.2M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 675,000 | 13.6M $ | as of Mar 31, 2026 |
Declared shareholders of KalVista Pharmaceuticals Inc
There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| SilverArc Capital Management, LLC and 1 other | 5.60 % | 2,876,407 | as of Mar 31, 2026 · SCHEDULE 13G |
| Glazer Capital, LLC and 1 other | 4.85 % | 2,581,700 | as of Jun 3, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 4.20 % | 2,136,940 | as of Mar 31, 2026 · SCHEDULE 13G |
| Integrated Core Strategies (US) LLC and 3 others | 3.70 % | 1,912,146 | as of Mar 31, 2026 · SCHEDULE 13G |
| Frazier Life Sciences Public Fund, L.P. and 13 others | 2.30 % | 1,249,165 | as of May 19, 2026 · SCHEDULE 13D |
Funds holding the debt of KalVista Pharmaceuticals Inc
4 funds declare 4 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Columbia Convertible Securities Fund | 1 | 7.8M $ | as of Feb 28, 2026 |
| Calamos Convertible Fund | 1 | 3M $ | as of Apr 30, 2026 |
| Buffalo High Yield Fund | 1 | 1.8M $ | as of Mar 31, 2026 |
| Harbor Ares Systematic Convertible Securities Fund | 1 | 172.2K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Funds holding KalVista Pharmaceuticals Inc". https://titelia.com/en/stocks/kalvista-pharmaceuticals-inc-US4834971032